SOURCE Select - China's Premier Pharma and Biotech Newswire
- ID: 1934760
- November 2015
- Region: China
- General Biologic
SOURCE SELECT is China's premier newswire, research tool, and customizable product tracking system dedicated to the pharmaceutical and biotechnology industry. This online and email alert service includes searchable access to more than 5,500 news briefs, 100+ special reports covering key aspects of the industry, a raw news database with comprising 130,000+ original articles and access to more than 45 interviews with top industry leaders.
GBI analysts monitor over 550 Chinese language news services and produce daily briefs covering industry developments. Briefs are categorized by theme, companies mentioned, and products. Alerts are customizable to track the products of your choice from registrations and pipeline movements to the latest news briefs and national policy releases.
Included with SOURCE SELECT is access to all back issues of the CPB Review (more than 3 years of searchable content), as well as monthly delivery of new issue of the CPB Review. Also included is full audio and transcriptions for exclusive interviews with industry leaders, as well as special reports covering key aspects of China's pharmaceutical industry.
SOURCE SELECT is an ideal news and research tool for managers, executives, and analysts that need to track China's industry in real-time, but do not require the depth, the data, or the analytics of SOURCE PROFESSIONAL or SOURCE LEGAL.
Your SOURCE SELECT subscription includes:
- Access to categorized and tagged Chinese industry news
- Daily English news briefs summarizing the most important events
- Customizable email alert system for news, policy, pipeline and registration changes
- Fully searchable historical news brief, interview and special report databases
- Access to CPB Review archive
- CPB Review delivered monthly in PDF format SHOW LESS READ MORE >